37 results on '"Crawley, Danielle"'
Search Results
2. Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden
3. Association of Gonadotropin-Releasing Hormone Agonists for Prostate Cancer With Cardiovascular Disease Risk and Hypertension in Men With Diabetes
4. Epidemiology of Bladder Cancer
5. Hormonal patterns in men with prediabetes and diabetes in NHANES III: possible links with prostate cancer
6. Exploring the association between use of gonadotropin releasing hormones agonists and prostate cancer diagnosis per se and diabetes control in men with type 2 diabetes mellitus: a nationwide, population-based cohort study
7. Exploring the Association Between Prostate Cancer Diagnosis per se and use of GnRH Agonists and Diabetes Control in Men with type 2 Diabetes Mellitus: A Nationwide, Population-Based Cohort Study
8. COVID-19 Risk Factors for Cancer Patients: A First Report with Comparator Data from COVID-19 Negative Cancer Patients
9. Abstract P28: COVID-19 infection and mortality in patients with skin malignancies receiving systemic anti-cancer therapy (SACT): The Guy’s Cancer Centre experience
10. Abstract P44: Factors affecting COVID-19 outcomes in cancer patients from Guy’s Cancer Center and King's College Hospital
11. Abstract S12-03: Clinical and demographic characteristics associated with shorter time to COVID-19 death
12. Abstract S11-03: The impact of COVID-19 in the cancer population stratified by age: A real-world data study from Guy’s Cancer Center
13. Use of Warfarin or Direct Oral Anticoagulants and Risk of Prostate Cancer in PCBaSe: A Nationwide Case-Control Study
14. Metabolic syndrome biomarkers and prostate cancer risk in the UK Biobank
15. Factors Affecting COVID-19 Outcomes in Cancer Patients: A First Report From Guy's Cancer Center in London
16. Association of type 2 diabetes mellitus and antidiabetic medication with risk of prostate cancer: a population-based case-control study
17. Association of baseline characteristics and survival in patients with advanced non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (CPIs): Real-world evidence.
18. Tuberculosis associated with Triplet therapy for lung cancer
19. Association of type 2 diabetes mellitus and antidiabetic medication with risk of prostate cancer: a population-based case-control study.
20. Association of type 2 diabetes mellitus and antidiabetic medication with risk of prostate cancer: a population-based case-control study.
21. Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy Results
22. Serum inflammatory markers in relation to prostate cancer severity and death
23. Does a prostate cancer diagnosis affect management of pre-existing diabetes? Results from PCBaSe Sweden: a nationwide cohort study
24. A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus
25. Serum inflammatory markers in relation to prostate cancer severity and death
26. Drugs for metabolic conditions and prostate cancer death in men on GnRH agonists
27. Metformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer
28. Association between type 2 diabetes, curative treatment and survival in men with intermediate‐ and high‐risk localized prostate cancer
29. Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer
30. Are you now a good surgeon? T2 positive margin status as a quality outcome measure following radical prostatectomy
31. Quantifying the Evidence for the Risk of Metabolic Syndrome and Its Components following Androgen Deprivation Therapy for Prostate Cancer: A Meta-Analysis
32. Serum glucose and risk of cancer: a meta-analysis
33. Obesity and cancer: the role of vitamin D
34. Development and characterization of eighty-four microsatellite markers for the red snapper (Lutjanus campechanus) using Illumina paired-end sequencing
35. Is there an anti-androgen withdrawal effect with enzalutamide?
36. Impact of pay for performance on quality of chronic disease management by social class group in England
37. Anti-Angiogenic Effect of Bortezomib in Patients with Multiple Myeloma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.